Donald Trump wearing a Foley catheter? POTUS' latest appearance sparks health concerns
President Donald Trump's recent White House appearance and at a UFC event in New Jersey sparked health concerns. Several social media users noted that they could see a bulge in his trouser leg, further fueling theories about the 78-year-old wearing a Foley catheter due to urinary incontinence or neurological issues. The Trump administration is yet to address these theories.
Images of Trump at the Rose Garden, where Trump inspected a construction project, and the UFC event, where he posed with champion Kayla Harrison, show a tube-like outline down his left pant leg.
Read More: Trump says he would 'certainly invoke' Insurrection Act if needed amid Los Angeles protests
'Trump is absolutely wearing a Foley catheter… It's a tube inserted into the bladder to drain urine into a bag strapped to the leg,' one person said on X, platform formerly known as Twitter. They further attached a photo of the president.
Another user, @Suzierizzo1, added, 'It definitely looks like Trump is wearing a Catheter most likely a Foley!'
Some X users dismissed the claims, attributing the bulge to wrinkled pants. X users commented, 'Wrinkles in his pants? Drrrr,' and 'Wrinkles in the suite? Who tf cares?' No medical evidence or official statement supports the catheter theory.
Read More: Trump stumbles on Air Force One steps, internet says 'Joe Biden vibes' | Video
In April, White House physician Captain Sean Barbabella declared Trump, 78, in 'excellent health' after a five-hour physical at Walter Reed, citing 'robust cardiac, pulmonary, neurological, and general physical function.'
The report noted a 20-pound weight loss, diverticulosis, a benign polyp, and a scar from a July 2024 assassination attempt, but no mention of catheters or incontinence.
Health concerns have dogged Trump, with 2022 photos suggesting a catheter bag and 2024 claims of incontinence. His physician's 2025 report omitted such issues, and Trump's active lifestyle, including golf, was cited as evidence of fitness.
Meanwhile, on Tuesday, Trump visited Fort Bragg, home to some 50,000 active-duty soldiers, for long-scheduled commemorations of the US Army's 250th anniversary following his move to deploy 700 Marines and 4,000 National Guard troops to Los Angeles.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
US green card rule change: New medical form needed each time you apply
Now, you will have to re-submit your medical form each time you apply for green card. In a fresh move by the Donald Trump administration, the US has changed the rules for green card applicants. From now on, the medical form submitted with an application—Form I-693—will no longer remain valid if that application is denied or withdrawn. You'll need a new one each time you apply. The new rule came into effect immediately after a notification from the US Citizenship and Immigration Services (USCIS) on June 11, 2025. 'Form I-693, Report of Immigration Medical Examination and Vaccination Record, signed by a civil surgeon on or after November 1, 2023, is only valid while the application the Form I-693 was submitted with is pending,' said USCIS. 'If the application a Form I-693 was submitted with is withdrawn or denied, that Form I-693 is no longer valid.' This update applies to all applications pending or filed on or after June 11, 2025. What changed and why? Until now, applicants were allowed to reuse their medical forms indefinitely, as long as they were completed after November 1, 2023. This policy was introduced in April 2024 to help applicants avoid delays or repeat visits to civil surgeons. But in its latest notification, USCIS said this approach was 'overly broad' and could 'potentially threaten public health.' 'By limiting the validity period to only the current immigration benefit application or request, we ensure that aliens get timely and proper medical examinations and treatment, which safeguards public health,' the agency added. Other green card changes under Trump USCIS has made several other changes to green card processing over the last year: 1. Social media disclosure proposal • Announced in March 2025 • Would require green card, asylum, refugee and naturalisation applicants to list social media handles • Open for public comment until May 5, 2025 2. Hold on asylum and refugee green cards • Started in late March 2025 • Processing paused for extra fraud and security reviews 3. Covid??'19 vaccine no longer required • USCIS stopped issuing RFEs or NOIDs related to Covid-19 vaccination from January 20, 2025 • The CDC removed COVID-19 from the required vaccine list on March 11, 2025 4. Extended green card validity for renewals • Since September 10, 2024, green cards are automatically extended for 36 months while Form I??'90 renewal is pending
Mint
3 hours ago
- Mint
Trump wants cheaper drugs like Europe has. How it works.
President Donald Trump doesn't just want to bring down prescription drug prices for Americans. He wants European countries to raise them to make up the revenue that drugmakers would lose from his policy. Trump is proposing a so-called most-favored-nation pricing model, which would set U.S. drug prices at the lowest level in other wealthy countries. But the pharmaceutical industry isn't buying into tying drug prices in the U.S. to prices in Europe—at least not knowing the details of the president's proposal. More details about the government's pricing model could come this week. On May 12, Trump directed government health officials to benchmark drug prices to international standards within 30 days. The lobbying group PhRMA, with members including U.S. pharma giants Eli Lilly, Pfizer, Johnson & Johnson, and AbbVie, has argued there are two reasons why U.S. drug prices are high: foreign countries not paying 'their fair share" for medicines, and middlemen such as pharmacy-benefit managers. Today, U.S. drug pricing is largely market driven. It involves negotiations between drug manufacturers, pharmacy-benefit managers, healthcare insurers and providers. European countries do it much differently. Each has its own way of determining drug prices, but most follow one of two broad approaches. The first approach, which Germany and France use, considers the overall clinical effectiveness of a new medicine. How does the new treatment compare to existing ones? Does it have added therapeutic benefits? If the new drug is substantially better, its price would reflect that. A second approach, used by the U.K., the Netherlands, and Sweden, analyzes cost effectiveness. This model not only compares the new drug to existing ones but also assesses the incremental value that the medicine brings to the health system. After the assessments, negotiations between drugmakers and the countries begin. Because many European countries have national health systems, they are in a strong negotiation position. If government negotiators think a medicine is too expensive for its effectiveness, they won't recommend its use. How Trump's MFN policy would work in practice isn't clear. Drug prices would probably be based on list prices in Europe since the prices paid by national health systems, or net prices, are confidential. The president's open-ended directive, laid out in an executive order, has many wondering how the U.S. could raise prices in Europe. Trump has made clear he wants to close the gap between U.S. and international prices, and has suggested he would use tariffs and export controls to achieve his goal. In theory, drugmakers could set list prices higher in Europe as long as it doesn't affect net prices, health policy expert Dr. Huseyin Naci told Barron's. In the U.K., for example, a higher list price could still lower the prices in other European countries. 'So that would still not be an acceptable approach to many other European countries," said Naci, who is associate professor of health policy at the London School of Economics. Overhauling Europe's decades-old pricing approaches would require fundamental changes to their pricing regulations—and there will be 'little appetite or ability" to alter them, Naci added. Cost is another complicating factor. 'Pharmaceutical spending is already one of the top categories of spending in many countries in terms of healthcare expenditure, so there's little room to accommodate higher prices and spending for pharmaceuticals in Europe," according to Naci. How Trump is planning to make Europeans pay more for drugs is the big question. He could use tariffs and trade negotiations as leverage. In early April, the president said a 'major" tax on pharmaceutical imports is coming 'very shortly," however nothing has been announced yet. In a trade agreement with the U.K. a month later, there is a provision on pharmaceuticals that states the U.K. will 'endeavor to improve the overall environment for pharmaceutical companies." What that means in practice still isn't clear. Write to Elsa Ohlen at
Hindustan Times
7 hours ago
- Hindustan Times
What is USCIS's new policy for green card applicants starting from 11 June? Here's a rundown
The United States Citizenship and Immigration Services (USCIS) has reversed a recent policy regarding medical examination forms required for green card applicants. What does the new policy say? Effective 11 June 2025, all new green card applications must include a fresh medical examination form, regardless of whether the applicant had submitted one previously. The agency's latest update replaces a policy introduced just over a year ago, which had allowed applicants to reuse Form I-693—the 'Report of Immigration Medical Examination and Vaccination Record'—indefinitely, as long as it was properly filled out and signed by a certified civil surgeon. ALSO READ| 'Won't tolerate visa abuse,' says US after video of handcuffed Indian student goes viral 'Form I-693, Report of Immigration Medical Examination and Vaccination Record, signed by a civil surgeon on or after Nov. 1, 2023, is only valid while the application the Form I-693 was submitted with is pending,' the USCIS said in its statement. 'If the application a Form I-693 was submitted with is withdrawn or denied, that Form I-693 is no longer valid. This guidance is effective immediately and applies to applications pending or filed on or after June 11, 2025.' It details that if a green card application is denied or withdrawn, the accompanying medical form cannot be reused. Any subsequent application will now require a new medical examination and an updated I-693 form. 'Most aliens subject to health-related grounds of inadmissibility must have an immigration medical examination to demonstrate they are not inadmissible,' USCIS added. 'In general, aliens applying to adjust status must submit Form I-693 to show they are free from any conditions that would render them inadmissible under the health-related grounds of inadmissibility. We may require an alien who would otherwise not be required to undergo an immigration medical examination to submit a Form I-693 as a matter of discretion, if the evidence indicates that there may be a public health concern.' The now-revoked April 2024 guidance had made the validity of Form I-693 indefinite. 'We have since determined that the April 4, 2024, policy is overly broad and could potentially threaten public health in the United States,' USCIS said. ALSO READ| Donald Trump launches $5 million immigration 'gold card' visa signup site
